Insulin resistance, evaluated by HOMA-IR, EHC, fasting or post-glucose insulin and glucose concentrations, did not differ between carriers and non-carriers of the gene variant, while the I148M variant had liver fat 73% more frequently than non-carriers [81]. This evidence concerns the gene INS and Insulin resistance.